News Snapshot:
Major pharmaceutical company Moderna announced Monday stage three clinical trials of a Wuhan coronavirus vaccine have been 94.5 percent effective. “This is a pivotal moment in the development of our COVID-19 vaccine candidate. Since early January, we have chased this virus with the intent to protect as many people around the world as possible. All along, we have known that each day matters. This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,†Moderna CEO Stéphane Bancel released in a statement. “This milestone is...
